Categories
News twelve

Fidia Pharma USA Inc to participate in the AOSSM 2012 Annual Meeting

Fidia Pharma USA Inc will be participating in the Annual Meeting of the American Orthopaedic Society for Sports Medicine (AOSSM) in Baltimore, MD, July 12-15, 2012. Please come and see us at booth 422-424.

We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee.

HYALGAN® is a treatment option for people who do not get adequate pain relief from simple painkillers (like Tylenol® or Advil®) or from exercise and physical therapy. HYALGAN® injections can be used in addition to prescription pain relievers (like Celebrex®).

AOSSM Preliminary Program

Our Four Leading Principles:

Innovation

Quality

Globalization

Competitiveness